Assessing EGFR‐mutated NSCLC with bone metastasis: Clinical features and optimal treatment strategy
Article in Cancer Medicine (March 2024)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Incidence of Bone Metastases and Skeletal-Related Events in Patients With EGFR-Mutated NSCLC Treated With Osimertinib
Article in JTO Clinical and Research Reports (April 2023)
Overall Survival Improvement in Patients with Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer and Bone Metastasis Treated with Denosumab
Article in Cancers (July 2022)